Who owns ACELRX PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Acelrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acelrx Pharmaceuticals stock

Who bought or sold ACELRX PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 2.0M $1.7M 0% Sep 2024
 View chart
Rosalind Advisors 759k $650k 0% Sep 2024
 View chart
Rock Springs Capital Management 317k $282k 0% Jun 2024
 View chart
MAI Wealth Advisors 282k $242k -1% Sep 2024
 View chart
Vanguard Group 241k $215k 36% Jun 2024
 View chart
Geode Capital Management 156k $133k 9% Sep 2024
 View chart
Values First Advisors 111k $95k -2% Sep 2024
 View chart
Susquehanna International 97k $83k 24% Sep 2024
 View chart
BlackRock 92k $78k 100% Sep 2024
 View chart
BlackRock 92k $82k 0% Jun 2024
 View chart
Royal Bank of Canada 85k $73k -57% Sep 2024
 View chart
Two Sigma Securities 39k $35k 100% Jun 2024
 View chart
State Street Corporation 22k $20k 0% Jun 2024
 View chart
United Bank 15k $13k 0% Sep 2024
 View chart
Northern Trust 11k $9.3k 0% Sep 2024
 View chart
Tower Research Capital 7.8k $7.0k -3% Jun 2024
 View chart
Sterling Capital Management 2.0k $1.7k 100% Sep 2024
 View chart
Group One Trading 1.7k $1.5k 0% Sep 2024
 View chart
Morgan Stanley 1.2k $1.0k -88% Jun 2024
 View chart
Wells Fargo & Company 758.00 $648.999600 -2% Sep 2024
 View chart
Goss Wealth Management 500.00 $445.000000 0% Jun 2024
 View chart
CoreCap Advisors 500.00 $428.000000 -72% Sep 2024
 View chart
Advisor Group Holdings 313.00 $266.989000 -76% Sep 2024
 View chart
Bank of America Corporation 180.00 $154.278000 29% Sep 2024
 View chart
Jpmorgan Chase & Co 141.00 $121.006200 236% Sep 2024
 View chart
Silicon Valley Capital Partners 137.00 $116.998000 0% Sep 2024
 View chart
Global Retirement Partners 73.00 $62.999000 0% Sep 2024
 View chart
Absolute Investment Management 50.00 $43.000000 0% Sep 2024
 View chart
Barclays 11.00 $0 100% Sep 2024
 View chart
Qube Research & Technologies 1.00 $1.000000 0% Jun 2024
 View chart

Who sold out of Acelrx Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Turtle Creek Wealth Advisors Jun 2024 72k $64k
Citadel Advisors Jun 2024 36k $32k
Simplex Trading Jun 2024 9.00 $0